Bio2Business is delighted to welcome CALIXAR as a SILVER Sponsor at BOS Manchester 2020. CALIXAR has developed unique technologies coupled with a state-of-the-art research platform enabling the production of novel therapeutic targets of the highest quality and covering all therapeutic areas. In particular, CALIXAR uses its patented technology platform for other companies that need to identify, express, extract, purify and stabilize native membrane proteins (GPCRs, ion channels, receptors, transporters and viral targets).
To find out more about CALIXAR pipeline, products, services and capabilities, click here to visit the website. In addition, click here to view one of our press releases reporting a successful achievement with Regeneron Pharmaceuticals Inc. for the discovery of new therapeutic antibodies from a high relevant target isolated thanks to CALIXAR platform.